Related Experiment Videos
Mycoses--prophylaxis and treatment.
Julia Warmińska1, Anna Kur, Joanna Bartosińska
1Chair and Department of Dermatology, Medical University of Lublin.
Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina
|August 25, 2004
Summary
Mycotic infections are increasing due to modern lifestyle and systemic diseases. Current treatments like azoles and allylamines are effective, but research continues for better antimycotic drugs.
Area of Science:
- Medical Mycology
- Infectious Diseases
Background:
- Rising incidence of mycotic infections observed globally.
- Factors contributing include industrialization, migration, urbanization, and lifestyle choices.
- Systemic conditions (diabetes, AIDS) and medications (corticosteroids, immunosuppressants) increase susceptibility to mycoses.
Purpose of the Study:
- To address the growing challenge of mycotic infections.
- To highlight the limitations of current treatments for chronic and recurrent mycoses.
- To emphasize the ongoing research for novel, cost-effective antimycotic agents.
Main Methods:
- Literature review on epidemiological trends of mycoses.
- Analysis of predisposing factors and common etiologies.
- Overview of existing antimycotic drug classes and their efficacy.
Main Results:
- Significant increase in mycotic infections linked to environmental and health factors.
- Mycoses are often chronic, difficult to treat, and prone to recurrence.
- Azoles and allylamines are currently the most effective treatments.
Conclusions:
- Urgent need for effective management strategies for increasing mycotic infections.
- Continued research and development of new antimycotic drugs are crucial.
- Focus on developing cheaper and more effective therapeutic options is essential.